Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

FRONTIER: An open-labelled study to characterise Fluciclovine (18F) uptake measured by positron emission tomography in breast cancer

Primary Publication: British Journal of Cancer, Translational Therapeutics,  November 18th 2021

Characterising 18F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging